177 related articles for article (PubMed ID: 15575906)
1. The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients.
Abbott KC; Lentine KL; Bucci JR; Agodoa LY; Peters TG; Schnitzler MA
Am J Transplant; 2004 Dec; 4(12):2032-7. PubMed ID: 15575906
[TBL] [Abstract][Full Text] [Related]
2. Outcomes associated with recipient and donor hepatitis C serology status after kidney transplantation in the United States: analysis of the USRDS/UNOS database.
Bucci JR; Lentine KL; Agodoa LY; Peters TG; Schnitzler MA; Abbott KC
Clin Transpl; 2004; ():51-61. PubMed ID: 16704138
[TBL] [Abstract][Full Text] [Related]
3. Association Between Declined Offers of Deceased Donor Kidney Allograft and Outcomes in Kidney Transplant Candidates.
Husain SA; King KL; Pastan S; Patzer RE; Cohen DJ; Radhakrishnan J; Mohan S
JAMA Netw Open; 2019 Aug; 2(8):e1910312. PubMed ID: 31469394
[TBL] [Abstract][Full Text] [Related]
4. Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.
Sawinski D; Forde KA; Lo Re V; Goldberg DS; Cohen JB; Locke JE; Bloom RD; Brensinger C; Weldon J; Shults J; Reese PP
Am J Kidney Dis; 2019 Jun; 73(6):815-826. PubMed ID: 30704882
[TBL] [Abstract][Full Text] [Related]
5. Impact of Willingness to Accept Hepatitis C Seropositive Kidneys Among Hepatitis C RNA-Positive Waitlisted Patients.
Sageshima J; Troppmann C; McVicar JP; Santhanakrishnan C; de Mattos AM; Perez RV
Transplantation; 2018 Jul; 102(7):1179-1187. PubMed ID: 29953423
[TBL] [Abstract][Full Text] [Related]
6. Survival Benefit of Transplantation with a Deceased Diabetic Donor Kidney Compared with Remaining on the Waitlist.
Cohen JB; Eddinger KC; Locke JE; Forde KA; Reese PP; Sawinski DL
Clin J Am Soc Nephrol; 2017 Jun; 12(6):974-982. PubMed ID: 28546439
[TBL] [Abstract][Full Text] [Related]
7. Preemptive deceased donor kidney transplantation: considerations of equity and utility.
Grams ME; Chen BP; Coresh J; Segev DL
Clin J Am Soc Nephrol; 2013 Apr; 8(4):575-82. PubMed ID: 23371953
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C and renal transplantation in the era of modern immunosuppression.
Abbott KC; Bucci JR; Matsumoto CS; Swanson SJ; Agodoa LY; Holtzmuller KC; Cruess DF; Peters TG
J Am Soc Nephrol; 2003 Nov; 14(11):2908-18. PubMed ID: 14569101
[TBL] [Abstract][Full Text] [Related]
9. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?
Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J
Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients.
Kadatz M; Klarenbach S; Gill J; Gill JS
Am J Transplant; 2018 Oct; 18(10):2457-2464. PubMed ID: 29797402
[TBL] [Abstract][Full Text] [Related]
11. Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus.
Abbott KC; Lentine KL; Bucci JR; Agodoa LY; Koff JM; Holtzmuller KC; Schnitzler MA
J Am Soc Nephrol; 2004 Dec; 15(12):3166-74. PubMed ID: 15579520
[TBL] [Abstract][Full Text] [Related]
12. Access to the kidney transplant waiting list: a time for reflection.
Pussell BA; Bendorf A; Kerridge IH
Intern Med J; 2012 Apr; 42(4):360-3. PubMed ID: 22498116
[TBL] [Abstract][Full Text] [Related]
13. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates.
Ojo AO; Hanson JA; Meier-Kriesche HU; Okechukwu CN; Wolfe RA; Leichtman AB; Agodoa LY; Kaplan B; Port FK
J Am Soc Nephrol; 2001 Mar; 12(3):589-597. PubMed ID: 11181808
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients.
Agbim U; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Maliakkal B; Nair S; Eason JD; Molnar MZ
Ren Fail; 2020 Nov; 42(1):767-775. PubMed ID: 32729359
[TBL] [Abstract][Full Text] [Related]
15. Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.
Bowring MG; Kucirka LM; Massie AB; Ishaque T; Bae S; Shaffer AA; Garonzik Wang J; Sulkowski M; Desai N; Segev DL; Durand CM
Transplantation; 2018 Dec; 102(12):2088-2095. PubMed ID: 29912046
[TBL] [Abstract][Full Text] [Related]
16. Obesity and gender-biased access to deceased donor kidney transplantation.
Ladhani M; Craig JC; Wong G
Nephrol Dial Transplant; 2020 Jan; 35(1):184-189. PubMed ID: 31203364
[TBL] [Abstract][Full Text] [Related]
17. Poor outcomes for children on the wait list at low-volume kidney transplant centers in the United States.
Rana A; Brewer ED; Scully BB; Kueht ML; Goss M; Halazun KJ; Liu H; Galvan NT; Cotton RT; O'Mahony CA
Pediatr Nephrol; 2017 Apr; 32(4):669-678. PubMed ID: 27757587
[TBL] [Abstract][Full Text] [Related]
18. Survival Benefit From Kidney Transplantation Using Kidneys From Deceased Donors Aged ≥75 Years: A Time-Dependent Analysis.
Pérez-Sáez MJ; Arcos E; Comas J; Crespo M; Lloveras J; Pascual J;
Am J Transplant; 2016 Sep; 16(9):2724-33. PubMed ID: 27004984
[TBL] [Abstract][Full Text] [Related]
19. Preemptive kidney transplantation in elderly recipients with kidneys discarded of very old donors: A good alternative.
Morales E; Gutiérrez E; Hernández A; Rojas-Rivera J; Gonzalez E; Hernández E; Polanco N; Praga M; Andrés A
Nefrologia; 2015; 35(3):246-55. PubMed ID: 26299167
[TBL] [Abstract][Full Text] [Related]
20. Are we underestimating the quality of aviremic hepatitis C-positive kidneys? Time to reconsider.
Sibulesky L; Kling CE; Blosser C; Johnson CK; Limaye AP; Bakthavatsalam R; Leca N; Perkins JD
Am J Transplant; 2018 Oct; 18(10):2465-2472. PubMed ID: 29451354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
